These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34408436)

  • 1. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
    Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
    Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
    Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
    Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How hsa-miR-495 performed in the tumorigenesis of pancreatic adenocarcinoma by bioinformatics analysis.
    Yang Y; Wang Y; Liu S; Zhao X; Jia R; Xiao Y; Zhang M; Li X; Li J; Wang W
    J Cell Biochem; 2019 May; 120(5):7802-7813. PubMed ID: 30485500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value and the Immune Microenvironment-associated Role of
    Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
    Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
    Luan H; Jian L; Huang Y; Guo Y; Zhou L
    Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
    Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
    Front Genet; 2022; 13():1022626. PubMed ID: 36685833
    [No Abstract]   [Full Text] [Related]  

  • 10. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
    Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
    Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Chen G; Song H; Yang Z; Du T; Zheng Y; Lu Z; Zhang K; Wei D
    Front Oncol; 2022; 12():890193. PubMed ID: 35619903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases.
    Wang Y; Yang Y; Wang Y; Li X; Xiao Y; Wang W
    Front Cell Dev Biol; 2020; 8():392. PubMed ID: 32582694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
    Li Y; Liu Z; Zhang Y
    BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma.
    Zhong B; Ma DD; Zhang T; Gong Q; Dong Y; Zhang JX; Li ZH; Jin WD
    Comb Chem High Throughput Screen; 2024; 27(7):1011-1021. PubMed ID: 37563820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
    Yu X; Sun R; Yang X; He X; Guo H; Ou C
    J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.